Company: DARE
Filing Date: 2025-08-14
Form Type: S-8
Source: 0001493152-25-011992
Chunk: 1

Company: Dare Bioscience, Inc.
Filing Date: 2025-08-14
Form: S-8
Chunk 1
---
-8 is being filed by Daré Bioscience, Inc. (“Daré”), with the U.S. Securities and Exchange Commission (the “Commission”) for the purpose of registering an additional 600,000 shares of its common stock that may be issued under the Daré 2022 Stock Incentive Plan (the “Original Plan”), as amended by Amendment No. 1 to the Daré 2022 Stock Incentive Plan (the “Plan Amendment”; the Original Plan as amended by the Plan Amendment, the “2022 Plan”). At Daré’s annual meeting of stockholders held on July 9, 2025, Daré’s stockholders approved the Plan Amendment to increase the number of shares of common stock reserved for issuance of awards under the 2022 Plan by 600,000.

Daré previously filed a Registration Statement on Form S-8 with the Commission on August 9, 2022 (File No. 333-266699) (the “Prior Registration Statement”) to register 1,349,479 shares of its common stock (after giving effect to the 1-for-12 reverse stock split effected in June 2024) for issuance under the Original Plan. This Registration Statement registers an additional 600,000 shares of Dare’s common stock for issuance under the 2022 Plan, thereby increasing the total number of shares of Dare’s common stock available for issuance under the 2022 Plan to 1,949,479.

This Registration Statement relates to securities of the same class as those registered under the Prior Registration Statement and is being filed in accordance with General Instruction E to Form S-8. Pursuant to such instruction, the contents of the Prior Registration Statement related to the 2022 Plan are hereby incorporated by reference in and made part of this Registration Statement, except to the extent supplemented, superseded or modified by the specific information set forth below and/or the specific exhibits attached under Item 8 hereto, pursuant to Rule 412 under the Securities Act of 1933, as amended (the “Securities Act”).

In accordance with the instructional Note to Part I of Form S-8, the information specified by Part I of Form S-8 has been omitted from this Registration Statement for offers of common stock pursuant to the 2022 Plan. The documents containing the information specified in Part I will be delivered to the participants in the 2022 Plan as required by Rule 428(b)(1) under the Securities Act.

| -2- |

<div align